Cargando…

Controlled drug release for inflammatory bowel disease (IBD)

Controlled drug release in formulation is an important area of research. Formulations using crospovidone as super-disintegrants to achieve immediate release once it reaches the ileo- cecal region is relevant. The Eudragit L30D pH dependent polymer that allows drug release after a lag time of 4-5 hrs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asha, D, Jeganath, S, Bupesh, G, Sahoo, UK, Bhaskar, M, Pandian, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2020
Materias:	Research-Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505240/ https://www.ncbi.nlm.nih.gov/pubmed/32994676 http://dx.doi.org/10.6026/97320630016513

Ejemplares similares

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

A short review on pharmacological activity of Cissus quadrangularis
por: Sundaran, Jeganath, et al.
Publicado: (2020)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
por: Imhann, Floris, et al.
Publicado: (2019)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
por: Murthy, Sanjay K, et al.
Publicado: (2023)

Nutritional Assessment in Inflammatory Bowel Disease (IBD)—Development of the Groningen IBD Nutritional Questionnaires (GINQ)
por: Peters, Vera, et al.
Publicado: (2019)

Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
por: Coward, Stephanie, et al.
Publicado: (2023)

Recipe for IBD: can we use food to control inflammatory bowel disease?
por: Witkowski, Mario, et al.
Publicado: (2017)

Correction to: The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
por: Imhann, Floris, et al.
Publicado: (2019)

Thromboembolic tendency (TE) in IBD (inflammatory bowel disease) patients
por: Canero, A, et al.
Publicado: (2010)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
por: Vadasz, Zahava, et al.
Publicado: (2015)

Improving pediatric Inflammatory Bowel Disease (IBD) follow-up
por: Dykes, Dana, et al.
Publicado: (2016)

Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland
por: Markiewicz-Łoskot, Grażyna, et al.
Publicado: (2023)

Impact of Different Nutrition Strategies on Patients with Inflammatory Bowel Disease (IBD)
por: Papadimitriou, Konstantinos, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD
por: Carroll, Matthew W, et al.
Publicado: (2019)

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD
por: Bernstein, Charles N, et al.
Publicado: (2019)

The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD
por: Kaplan, Gilaad G, et al.
Publicado: (2023)

Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2022)

From bowel inflammation to the bone and joints: musculoskeletal examination in inflammatory bowel disease (IBD)
por: Tavassoli, Samane, et al.
Publicado: (2021)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
por: Singh, Arshdeep, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada
por: Rose, Keeley L, et al.
Publicado: (2019)

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

Neutrophil-to-Lymphocyte Ratio (NLR) in Canine Inflammatory Bowel Disease (IBD)
por: Benvenuti, Elena, et al.
Publicado: (2020)

Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry
por: Torres, Esther A., et al.
Publicado: (2012)

Detection of Anti-Erythrocyte Antibodies in Dogs with Inflammatory Bowel Disease (IBD)
por: Gori, Eleonora, et al.
Publicado: (2021)

Bioelectronics in the brain–gut axis: focus on inflammatory bowel disease (IBD)
por: Stakenborg, Nathalie, et al.
Publicado: (2021)

Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs
por: Zhang, Shuxia, et al.
Publicado: (2022)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors
por: Shaffer, Seth R, et al.
Publicado: (2023)

Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD
por: Damas, Oriana M., et al.
Publicado: (2022)

The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review
por: Jakubczyk, Dominika, et al.
Publicado: (2020)

In-Silico Analysis of Inflammatory Bowel Disease (IBD) GWAS Loci to Novel Connections
por: Mesbah-Uddin, Md., et al.
Publicado: (2015)

Metabolic Host–Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD)
por: Dowdell, Alexander S., et al.
Publicado: (2021)

S10.3d Yeast Microbiome in patients with inflammatory bowel disease (IBD)
por: Vaezi, Afsane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2fm70eg43uosdm26q5ndk0moui